000 01593cam  2200325zi 4500
0019.917257
003CaOODSP
00520230404110808
006m     o  d f      
007cr |||||||||||
008221114t20222022oncbd   os   f000 0 eng d
020 |a9780660462387
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-326/2022E-PDF
24500|aTrends in pre-exposure prophylaxis (PrEP) use in nine Canadian provinces, 2018-2021.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c[2022]
264 4|c©2022
300 |a1 online resource (1 page) : |bcolour map, colour graphs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Tendances d'utilisation de la prophylaxie pré-exposition contre le VIH (PPrE) dans neuf provinces canadiennes, 2018-2021.
650 0|aPre-exposure prophylaxis|zCanada|vStatistics.
655 7|aStatistics|2lcgft
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tTendances d'utilisation de la prophylaxie pré-exposition contre le VIH (PPrE) dans neuf provinces canadiennes, 2018-2021.|w(CaOODSP)9.917258
85640|qPDF|s340 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-326-2022-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/diseases-conditions/trends-pre-exposure-prophylaxis-use-in-9-canadian-provinces-2018-2021-infographic.html